The CyMVO is the owner of the Medicines Verification System and its role will be to ensure the smooth operation of the system, the integrity of the data stored in the National Repository and last but not least, to ensure the Quality and Safety of the data that will be exchanged and stored. System audits will be carried out making use of Standard Operating Procedures which will be applicable across the entire range of system operation.

The European Medicines Verification Agency (EMVO) will perform audits on the implementation of the Quality Assurance procedures effected by the CyMVO as any inadequate implementation of the quality system may endanger data security at pan-European level. The communication of the CyMVO with all stakeholders using the system, the competent authorities in Cyprus and with the corresponding organizations of other European Countries (NMVO’s) is expected to be on a continuous basis.